

ChromCore RP columns are suited for a broad range of applications, including pharmaceutical, food and beverage, clinical diagnostics, chemical, environmental, consumer products, and more.

ChromCore Phenyl-Hexyl columns are based on high surface coverage hexylbenzene modified silica particles with exhaustive end-capping. They are designed for a broad range of applications that require enhanced hydrophobic retention and selectivity towards aromatic analytes, such as isomers of aromatic and heterocyclic pharmaceuticals and catechins.

ChromCore Phenyl-Ether columns are based on high surface coverage ethoxybenzene modified silica particles with exhaustive end-capping. They are designed for a broad range of applications that require selectivity towards aromatic analytes, such as isomers of aromatic and heterocyclic pharmaceuticals and catechins.

ChromCore PFP columns are based on pentafluorobenzene (PFP) modified silica particles with exhaustive end-capping. They are designed for a broad range of applications that require selectivity different from ChromCore Phenyl for aromatic analytes, such as halogenated aromatic compounds and Vitamin E isomers.

ChromCore Biphenyl columns are based on high surface coverage biphenyl modified silica particles with exhaustive end-capping. They are designed for applications that require different selectivity towards aromatic analytes compared to ChromCore Phenyl or ChromCore PFP columns.

ChromCore 120 C18-T columns are based on bonding C18 functional groups to the surface of high-purity, monodispersed, porous silica particles through three siloxane linkages, designed for applications that require extended pH range or high shape selectivity.

ChromCore AQ C8 columns are based on high surface coverage C8 modified silica particles with exhaustive end-capping to minimize undesired silanol activity, designed for separating analytes with intermediate to high hydrophobicity in highly aqueous mobile phase.

ChromCore 120 C8 columns are based on high surface coverage C8 modified silica particles with exhaustive end-capping to minimize undesired silanol activity, designed for separating analytes with intermediate to high hydrophobicity.

ChromCore 300 Å reversed phase columns are based on monodispersed, wide-pore, high-purity, spherical silica particles modified with C18, C8 or C4 functionalities and exhaustive end-capping. They are designed for separating analytes of large size, such as ginsenosides, PEG derivatives, peptides and small proteins.